Financial results for the period ended September 30, 2026
As filed · Shilpa Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
What happened
FactFinancial results for the period ended September 30, 2026. Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2026. The said Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedWe will try to monetize all these investments.
We should be doing another about INR75 crores to INR100 crores from here on.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- So we are expecting to start our clinical study, Phase III clinical study, in Q4 FY '26. (management committed by Q4 FY26)
- We should be doing another about INR75 crores to INR100 crores from here on. (management committed by FY26)
Evidence
- Shilpa Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q2 FY26
- Latest statement · Q2 FY26
- Earlier statement · Q2 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%